Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000080

EVP, Chf Clinical Develop Ofcr sold 1,484 shares at $32.20 ($47,780)

  • EVP, Chf Clinical Develop Ofcr acquired 4,032 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-30 Grant or award : show line 1 in the form +4,032 62,540 D
2025-01-31 Sale : show line 2 in the form −1,484 $32.20 $47,780 61,056 D
Open-market sales · 1,484 sh · avg $32.20 · $47,780
Loading xslF345X05/edgardoc.xml…